Lysosome-targeting chimeras evolve | Nature Chemical Biology
LYTACs induce selective degradation of extracellular proteins by recruiting them to cellular receptors that mediate delivery to the lysosome. Recent development of GalNAc-LYTACs and MoDE-As targeting the liver-specific ASGPR enables cell-type-restricted lysosomal protein degradation and reveals new LYTAC design principles.
Subjects Chemical tools Post-translational modifications Proteases LYTACs induce selective degradation of extracellular proteins by recruiting them to cellular receptors that mediate delivery to the lysosome. Recent development of GalNAc-LYTACs and MoDE-As targeting the liver-specific ASGPR enables cell-type-restricted lysosomal protein degradation and reveals new LYTAC design principles. Access to this article via ICE Institution of Civil Engineers is not available. Change institution Buy or subscribe This is a preview of subscription content, access via your institution Relevant articles Ope
Explore this link on the map →saved by
related reading
- Protein degradation reaches further outnature.com
- Lysosome-targeting chimaeras for degradation of extracellular proteins | Naturenature.com
- The ins and outs of phospholipid asymmetry in the plasma membrane: roles in health and disease - PMCncbi.nlm.nih.gov
- The novel mechanism of lenalidomide activity - PMCncbi.nlm.nih.gov
- The current state and future directions of RNAi-based therapeutics | Nature Reviews Drug Discoverynature.com
- Polyadenylation and nuclear export of mRNAs - PMCncbi.nlm.nih.gov
- Sci-Hubsci-hub.box
- UGCG and the glycosphingolipid rheostat: a metabolic checkpoint governing immune activation and tumor immune evasion | Signal Transduction and Targeted Therapynature.com
- Engineering Plastic-Degrading Enzymes and PCSK9 Binders with Protein AI Toolsblog.latch.bio
- ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now? - PubMedpubmed.ncbi.nlm.nih.gov
- Eliglustat - Wikipediaen.wikipedia.org
- Has pancreatic cancer met its match?worksinprogress.co